Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Is daily physical activity affected by dynamic hyperinflation in adults with cystic fibrosis?

Savi D, Di Paolo M, Simmonds NJ, Pascucci C, Quattrucci S, Palange P.

BMC Pulm Med. 2018 Apr 19;18(1):60. doi: 10.1186/s12890-018-0623-7.

2.

[Italian Cystic Fibrosis Registry. Report 2011-2014].

Giordani B, Amato A, Majo F, Ferrari G, Quattrucci S, Minicucci L, Padoan R, Floridia G, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC.

Epidemiol Prev. 2018 Jan-Feb;42(1S1):1-32. doi: 10.19191/EP18.1-S1.P001.001. Italian.

3.

Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Pascucci C, De Biase RV, Savi D, Quattrucci S, Isidori AM, Lubrano C, Gnessi L, Lenzi A.

J Endocrinol Invest. 2018 May;41(5):591-596. doi: 10.1007/s40618-017-0784-x. Epub 2017 Nov 2.

PMID:
29098662
4.

Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.

Nenna R, Midulla F, Lambiase C, De Castro G, Zicari AM, Indinnimeo L, Cimino G, Troiani P, Quattrucci S, Tancredi G.

Ital J Pediatr. 2017 Jul 15;43(1):60. doi: 10.1186/s13052-017-0376-6.

5.

Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.

Terlizzi V, Castaldo G, Salvatore D, Lucarelli M, Raia V, Angioni A, Carnovale V, Cirilli N, Casciaro R, Colombo C, Di Lullo AM, Elce A, Iacotucci P, Comegna M, Scorza M, Lucidi V, Perfetti A, Cimino R, Quattrucci S, Seia M, Sofia VM, Zarrilli F, Amato F.

J Med Genet. 2017 Apr;54(4):224-235. doi: 10.1136/jmedgenet-2016-103985. Epub 2016 Oct 13.

6.

The Impact on Genetic Testing of Mutational Patterns of CFTR Gene in Different Clinical Macrocategories of Cystic Fibrosis.

Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Testino G, Truglio G, Strom R, Quattrucci S.

J Mol Diagn. 2016 Jul;18(4):554-65. doi: 10.1016/j.jmoldx.2016.02.007. Epub 2016 May 5.

PMID:
27157324
7.

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis.

Savi D, Simmonds N, Di Paolo M, Quattrucci S, Palange P, Banya W, Hopkinson NS, Bilton D.

BMC Pulm Med. 2015 Dec 1;15:151. doi: 10.1186/s12890-015-0151-7.

8.

Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT.

Ciet P, Serra G, Bertolo S, Spronk S, Ros M, Fraioli F, Quattrucci S, Assael MB, Catalano C, Pomerri F, Tiddens HA, Morana G.

Eur Radiol. 2016 Mar;26(3):780-7. doi: 10.1007/s00330-015-3850-9. Epub 2015 May 30.

PMID:
26024847
9.

Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis.

Savi D, Di Paolo M, Simmonds N, Onorati P, Internullo M, Quattrucci S, Winston B, Laveneziana P, Palange P.

BMC Pulm Med. 2015 May 9;15:59. doi: 10.1186/s12890-015-0036-9.

10.

A Genotypic-Oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic Fibrosis.

Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Stamato A, Narzi F, Amato A, Cimino G, Bertasi S, Quattrucci S, Strom R.

Mol Med. 2015 Apr 21;21:257-75. doi: 10.2119/molmed.2014.00229.

11.

Clinical expression of patients with the D1152H CFTR mutation.

Terlizzi V, Carnovale V, Castaldo G, Castellani C, Cirilli N, Colombo C, Corti F, Cresta F, D'Adda A, Lucarelli M, Lucidi V, Macchiaroli A, Madarena E, Padoan R, Quattrucci S, Salvatore D, Zarrilli F, Raia V.

J Cyst Fibros. 2015 Jul;14(4):447-52. doi: 10.1016/j.jcf.2014.12.012. Epub 2015 Jan 10.

12.

Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis.

Calabrese C, Tosco A, Abete P, Carnovale V, Basile C, Magliocca A, Quattrucci S, De Sanctis S, Alatri F, Mazzarella G, De Pietro L, Turino C, Melillo E, Buonpensiero P, Di Pasqua A, Raia V.

J Cyst Fibros. 2015 Mar;14(2):203-10. doi: 10.1016/j.jcf.2014.09.014. Epub 2014 Nov 4.

13.

Cystic fibrosis and new trends by ophthalmological evaluation: a pilot study.

Nebbioso M, Quattrucci S, Leggieri E, Spadea L, Vingolo EM.

Biomed Res Int. 2014;2014:580373. doi: 10.1155/2014/580373. Epub 2014 Jul 15.

14.

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates.

Iebba V, Totino V, Santangelo F, Gagliardi A, Ciotoli L, Virga A, Ambrosi C, Pompili M, De Biase RV, Selan L, Artini M, Pantanella F, Mura F, Passariello C, Nicoletti M, Nencioni L, Trancassini M, Quattrucci S, Schippa S.

Front Microbiol. 2014 Jun 5;5:280. doi: 10.3389/fmicb.2014.00280. eCollection 2014.

15.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM; Cystic Fibrosis Ataluren Study Group.

Lancet Respir Med. 2014 Jul;2(7):539-47. doi: 10.1016/S2213-2600(14)70100-6. Epub 2014 May 15.

16.

Burkholderia pyrrocinia in cystic fibrosis lung transplantation: a case report.

Savi D, De Biase RV, Amaddeo A, Anile M, Venuta F, Ruberto F, Simmonds N, Cimino G, Quattrucci S.

Transplant Proc. 2014 Jan-Feb;46(1):295-7. doi: 10.1016/j.transproceed.2013.08.108.

PMID:
24507071
17.

Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate.

Bianchi ML, Colombo C, Assael BM, Dubini A, Lombardo M, Quattrucci S, Bella S, Collura M, Messore B, Raia V, Poli F, Bini R, Albanese CV, De Rose V, Costantini D, Romano G, Pustorino E, Magazzù G, Bertasi S, Lucidi V, Traverso G, Coruzzo A, Grzejdziak AD.

Lancet Respir Med. 2013 Jul;1(5):377-85. doi: 10.1016/S2213-2600(13)70064-X. Epub 2013 Jun 2.

PMID:
24429202
18.

Measuring habitual physical activity in adults with cystic fibrosis.

Savi D, Quattrucci S, Internullo M, De Biase RV, Calverley PM, Palange P.

Respir Med. 2013 Dec;107(12):1888-94. doi: 10.1016/j.rmed.2013.09.012. Epub 2013 Sep 22.

19.

Clinical effects of diet supplementation with DHA in pediatric patients suffering from cystic fibrosis.

Leggieri E, De Biase RV, Savi D, Zullo S, Halili I, Quattrucci S.

Minerva Pediatr. 2013 Aug;65(4):389-98.

PMID:
24051972
20.

Reactive-oxygen-species-mediated P. aeruginosa killing is functional in human cystic fibrosis macrophages.

Cifani N, Pompili B, Anile M, Patella M, Diso D, Venuta F, Cimino G, Quattrucci S, Di Domenico EG, Ascenzioni F, Del Porto P.

PLoS One. 2013 Aug 19;8(8):e71717. doi: 10.1371/journal.pone.0071717. eCollection 2013.

21.

Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.

Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.

J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):133-7. doi: 10.1089/jamp.2012.1034. Epub 2013 Jun 8.

PMID:
23745525
22.

Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients.

Megiorni F, Cialfi S, Cimino G, De Biase RV, Dominici C, Quattrucci S, Pizzuti A.

J Cyst Fibros. 2013 Dec;12(6):797-802. doi: 10.1016/j.jcf.2013.03.007. Epub 2013 Apr 28.

23.

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.

Schippa S, Iebba V, Santangelo F, Gagliardi A, De Biase RV, Stamato A, Bertasi S, Lucarelli M, Conte MP, Quattrucci S.

PLoS One. 2013 Apr 17;8(4):e61176. doi: 10.1371/journal.pone.0061176. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/a8b06cd3-c8a8-48fa-9748-b04fded4b963.

24.

Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation.

Venuta F, Tonelli AR, Anile M, Diso D, De Giacomo T, Ruberto F, Russo E, Rolla M, Quattrucci S, Rendina EA, Li Phd N, Coloni GF.

J Cardiovasc Surg (Torino). 2012 Dec;53(6):817-20.

PMID:
23207567
25.

Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation.

Venuta F, Tonelli AR, Anile M, Diso D, De Giacomo T, Ruberto F, Russo E, Rolla M, Quattrucci S, Rendina EA, Li Phd N, Coloni GF.

J Cardiovasc Surg (Torino). 2012 May 28. [Epub ahead of print]

PMID:
22669100
26.

Scedosporium apiospermum atrial mycetomas after lung transplantation for cystic fibrosis.

Miraldi F, Anile M, Ruberto F, Tritapepe L, Puglese F, Quattrucci S, Messina T, Vitolo D, Venuta F.

Transpl Infect Dis. 2012 Apr;14(2):188-91. doi: 10.1111/j.1399-3062.2011.00679.x. Epub 2011 Sep 28.

PMID:
22093620
27.

Synergistic post-transcriptional regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 specific binding.

Megiorni F, Cialfi S, Dominici C, Quattrucci S, Pizzuti A.

PLoS One. 2011;6(10):e26601. doi: 10.1371/journal.pone.0026601. Epub 2011 Oct 20.

28.

Validation of a predictive survival model in Italian patients with cystic fibrosis.

Buzzetti R, Alicandro G, Minicucci L, Notarnicola S, Furnari ML, Giordano G, Lucidi V, Montemitro E, Raia V, Magazzù G, Vieni G, Quattrucci S, Ferrazza A, Gagliardini R, Cirilli N, Salvatore D, Colombo C.

J Cyst Fibros. 2012 Jan;11(1):24-9. doi: 10.1016/j.jcf.2011.08.007. Epub 2011 Sep 23.

29.

Chronic expectoration of staples after reductive pneumoplasty in a lung transplantation patient.

Venuta F, Anile M, Diso D, de Giacomo T, Rendina EA, Quattrucci S, Coloni GF.

Ann Thorac Surg. 2011 Aug;92(2):775. doi: 10.1016/j.athoracsur.2011.05.024. No abstract available.

PMID:
21801948
30.

Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa.

Del Porto P, Cifani N, Guarnieri S, Di Domenico EG, Mariggiò MA, Spadaro F, Guglietta S, Anile M, Venuta F, Quattrucci S, Ascenzioni F.

PLoS One. 2011;6(5):e19970. doi: 10.1371/journal.pone.0019970. Epub 2011 May 18.

31.

Lung transplantation for cystic fibrosis after thoracic surgical procedures.

Rolla M, Anile M, Venuta F, Diso D, Quattrucci S, De Giacomo T, Russo E, Ruberto F, Rendina EA, Furio Coloni G.

Transplant Proc. 2011 May;43(4):1162-3. doi: 10.1016/j.transproceed.2011.01.132.

PMID:
21620078
32.

A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal.

Massai F, Imperi F, Quattrucci S, Zennaro E, Visca P, Leoni L.

Biosens Bioelectron. 2011 Apr 15;26(8):3444-9. doi: 10.1016/j.bios.2011.01.022. Epub 2011 Jan 25.

PMID:
21324665
33.

A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.

Crovella S, Segat L, Amato A, Athanasakis E, Bezzerri V, Braggion C, Casciaro R, Castaldo G, Colombo C, Covone AE, De Rose V, Gagliardini R, Lanzara C, Minicucci L, Morgutti M, Nicolis E, Pardo F, Quattrucci S, Raia V, Ravazzolo R, Seia M, Stanzial V, Termini L, Zazzeron L, Cabrini G, Gasparini P.

Clin Chem Lab Med. 2011 Jan;49(1):49-54. doi: 10.1515/CCLM.2011.023. Epub 2010 Nov 16.

PMID:
21077791
34.

Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study.

Pieroni L, Finamore F, Ronci M, Mattoscio D, Marzano V, Mortera SL, Quattrucci S, Federici G, Romano M, Urbani A.

Mol Biosyst. 2011 Mar;7(3):630-9. doi: 10.1039/c0mb00135j. Epub 2010 Nov 12.

PMID:
21072441
35.

Neutrophil unsaturated fatty acid release by GM-CSF is impaired in cystic fibrosis.

Bravo E, Napolitano M, Valentini SB, Quattrucci S.

Lipids Health Dis. 2010 Nov 8;9:129. doi: 10.1186/1476-511X-9-129.

36.

A new complex allele of the CFTR gene partially explains the variable phenotype of the L997F mutation.

Lucarelli M, Narzi L, Pierandrei S, Bruno SM, Stamato A, d'Avanzo M, Strom R, Quattrucci S.

Genet Med. 2010 Sep;12(9):548-55. doi: 10.1097/GIM.0b013e3181ead634.

PMID:
20706124
37.

Evaluation of a home telemonitoring service for adult patients with cystic fibrosis: a pilot study.

Grzincich G, Gagliardini R, Bossi A, Bella S, Cimino G, Cirilli N, Viviani L, Iacinti E, Quattrucci S.

J Telemed Telecare. 2010;16(7):359-62. doi: 10.1258/jtt.2010.091006. Epub 2010 Jul 19.

PMID:
20643846
38.

Clostridium difficile-related pancolitis in lung-transplanted patients with cystic fibrosis.

Patriarchi F, Rolla M, Maccioni F, Menichella A, Scacchi C, Ambrosini A, Costantino A, Quattrucci S.

Clin Transplant. 2011 Jan-Feb;25(1):E46-51. doi: 10.1111/j.1399-0012.2010.01316.x.

PMID:
20642799
39.

Treatment of complex airway lesions after lung transplantation with self-expandable nitinol stents: early experience.

Anile M, Venuta F, Diso D, Liparulo V, Ricella C, De Giacomo T, Pugliese F, Rolla M, Quattrucci S, Pecoraro Y, Rendina EA, Coloni GF.

Transplant Proc. 2010 May;42(4):1279-80. doi: 10.1016/j.transproceed.2010.03.092.

PMID:
20534280
40.

Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response.

Mattoscio D, Evangelista V, De Cristofaro R, Recchiuti A, Pandolfi A, Di Silvestre S, Manarini S, Martelli N, Rocca B, Petrucci G, Angelini DF, Battistini L, Robuffo I, Pensabene T, Pieroni L, Furnari ML, Pardo F, Quattrucci S, Lancellotti S, Davì G, Romano M.

FASEB J. 2010 Oct;24(10):3970-80. doi: 10.1096/fj.10-159921. Epub 2010 Jun 8.

PMID:
20530751
41.

Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.

Magni A, Trancassini M, Varesi P, Iebba V, Curci A, Pecoraro C, Cimino G, Schippa S, Quattrucci S.

J Clin Microbiol. 2010 Apr;48(4):1035-9. doi: 10.1128/JCM.02060-09. Epub 2010 Jan 27. Erratum in: J Clin Microbiol. 2010 Jul;48(7):2664.

42.

Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis.

Iuliano L, Monticolo R, Straface G, Zullo S, Galli F, Boaz M, Quattrucci S.

Am J Clin Nutr. 2009 Sep;90(3):477-84. doi: 10.3945/ajcn.2009.27757. Epub 2009 Jul 8.

PMID:
19587087
43.

Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.

Marzuillo C, De Giusti M, Tufi D, Giordano A, Del Cimmuto A, Quattrucci S, Mancini C, Villari P.

Infect Control Hosp Epidemiol. 2009 Aug;30(8):753-8. doi: 10.1086/598683.

PMID:
19583515
44.

Neutrophil generation of inflammatory precursors is not modulated by docosahexaenoic acid.

Quattrucci S, Napolitano M, Valentini SB, Giuliani A, Bravo E.

Inflamm Res. 2009 Oct;58(10):677-85. doi: 10.1007/s00011-009-0035-5. Epub 2009 Mar 31.

PMID:
19333722
45.

Lung transplantation for cystic fibrosis in Italy.

Quattrucci S, Cimino G, Bertasi S, Benedetti Valentini S, Bossi A, D'Alu V, Locorriere L, Scacchi C, Rolla M; Italian Group for Lung Transplantation.

Transplant Proc. 2008 Jul-Aug;40(6):2003-5. doi: 10.1016/j.transproceed.2008.05.036.

PMID:
18675114
46.

Lung transplantation for cystic fibrosis: ten years of experience.

Aratari MT, Venuta F, De Giacomo T, Rendina EA, Anile M, Diso D, Francioni F, Quattrucci S, Rolla M, Pugliese F, Liparulo V, Di Stasio M, Ricella C, Tsagkaropoulos S, Ferretti G, Coloni GF.

Transplant Proc. 2008 Jul-Aug;40(6):2001-2. doi: 10.1016/j.transproceed.2008.05.029.

PMID:
18675113
47.

Improved results with lung transplantation for cystic fibrosis: a 6-year experience.

Venuta F, Quattrucci S, Rendina EA, De Giacomo T, Mercadante E, Moretti M, Cimino G, Coloni GF.

Interact Cardiovasc Thorac Surg. 2004 Mar;3(1):21-4.

PMID:
17670168
48.

Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.

Narzi L, Ferraguti G, Stamato A, Narzi F, Valentini SB, Lelli A, Delaroche I, Lucarelli M, Strom R, Quattrucci S.

Clin Genet. 2007 Jul;72(1):39-46.

PMID:
17594398
49.

Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance.

Magni A, Giordano A, Mancini C, Pecoraro C, Varesi P, Quattrucci S, Trancassini M.

New Microbiol. 2007 Jan;30(1):59-62.

50.

Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.

Vizza CD, Letizia C, Badagliacca R, Sciomer S, Poscia R, Della Rocca G, Iacoboni C, Leonardo de L, Quattrucci S, Dario C, Luigi P, Fedele F.

Regul Pept. 2006 Sep 11;136(1-3):85-91. Epub 2006 Jun 30.

PMID:
16815566

Supplemental Content

Loading ...
Support Center